Clinician perspectives on preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies.

被引：0
|
作者：
Lau-Min, Kelsey S. [1 ]
Varughese, Lisa A. [2 ]
Nelson, Maria N. [3 ]
Cambareri, Christine [4 ]
Reddy, Nandi J. [5 ]
Oyer, Randall A. [5 ]
Teitelbaum, Ursina R. [1 ]
Tuteja, Sony [2 ]
机构：
[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Mixed Methods Res Lab, Philadelphia, PA 19104 USA
[4] Hosp Univ Penn, Dept Pharm, 3400 Spruce St, Philadelphia, PA 19104 USA
[5] Penn Med Lancaster Gen Hlth, Ann B Barshinger Canc Inst, Lancaster, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.54
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
54
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
    Kelsey S. Lau-Min
    Lisa A. Varughese
    Maria N. Nelson
    Christine Cambareri
    Nandi J. Reddy
    Randall A. Oyer
    Ursina R. Teitelbaum
    Sony Tuteja
    BMC Cancer, 22
  • [2] Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
    Lau-Min, Kelsey S.
    Varughese, Lisa A.
    Nelson, Maria N.
    Cambareri, Christine
    Reddy, Nandi J.
    Oyer, Randall A.
    Teitelbaum, Ursina R.
    Tuteja, Sony
    BMC CANCER, 2022, 22 (01)
  • [3] Integrating comprehensive point of care and preemptive pharmacogenomic testing for patients with gastrointestinal malignancies.
    Hughes, Caren
    Baldeo, Candice
    Rodgers, Jessica M.
    Ritter, Ashton
    Koep, Tyler
    Schnettler, Erica
    Kasi, Pashtoon Murtaza
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Circulating tumor DNA testing and research in patients with gastrointestinal malignancies.
    Shahjehan, Faisal
    Kamatham, Saivaishnavi
    Kasi, Pashtoon Murtaza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
    Ragia, Georgia
    Maslarinou, Anthi
    Atzemian, Natalia
    Biziota, Eirini
    Koukaki, Triantafyllia
    Ioannou, Charalampia
    Balgkouranidou, Ioanna
    Kolios, George
    Kakolyris, Stylianos
    Xenidis, Nikolaos
    Amarantidis, Kyriakos
    Manolopoulos, Vangelis G.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers
    Keeling, Nicholas J.
    Rosenthal, Meagen M.
    West-Strum, Donna
    Patel, Amit S.
    Haidar, Cyrine E.
    Hoffman, James M.
    GENETICS IN MEDICINE, 2019, 21 (05) : 1224 - 1232
  • [7] Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid
    Girdwood, Sonya Tang
    Hall, Matthew
    Antoon, James W.
    Kyler, Kathryn E.
    Williams, Derek J.
    Shah, Samir S.
    Orth, Lucas E.
    Goldman, Jennifer
    Feinstein, James A.
    Ramsey, Laura B.
    JAMA NETWORK OPEN, 2024, 7 (02) : E2355707
  • [8] A prospective pilot study of pharmacogenetic-based dosing of 5-fluouracil (5-FU) and irinotecan (IRI) in patients (pts) with gastrointestinal (GI) malignancies.
    Chi, Jeffrey
    Hakim, Nausheen
    Rehman, Hasan
    Moriarty, Linda
    Maloney, Antonia
    Smith, Melissa H.
    Jose, Jyothi
    Saif, Wasif M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Patients' Perspectives on Psychiatric Pharmacogenetic Testing
    Liko, Ina
    Lai, Erika
    Griffin, Rachel J.
    Aquilante, Christina L.
    Lee, Yee Ming
    PHARMACOPSYCHIATRY, 2020, 53 (06) : 256 - 261
  • [10] Patients' and physicians' perspectives on pharmacogenetic testing
    Rogausch, A
    Prause, D
    Schallenberg, A
    Brockmöller, J
    Himmel, W
    PHARMACOGENOMICS, 2006, 7 (01) : 49 - 59
12345